v3.24.0.1
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Cash flows from operating activities:      
Net income (loss) $ (46,496) $ (163,747) $ 12,786
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:      
Depreciation and amortization 16,607 17,132 12,600
Estimated credit losses 955 1,737 1,428
Share-based compensation 3,171 4,967 6,585
Impairment loss related to goodwill and intangible assets 15,526 127,831 0
Impairment loss on operating lease right-of-use assets 133 0 0
Provision for deferred income taxes 0 (2,359) 1,609
Loss on disposal of fixed assets 218 568 198
Change in value of marketable securities (1,438) 0 0
(Increase) decrease in:      
Accounts and notes receivable (300) (3,106) (1,896)
Inventory 13,773 32,890 (34,690)
Prepaid expenses and other assets 3,898 10,827 (9,937)
Accounts payable and accrued liabilities (3,035) (3,359) 3,285
Operating leases 46 508 1,282
Customer deposits 1,021 (8,590) 6,362
Payroll and payroll tax liabilities (2,502) (2,769) 4,785
Sales taxes payable (156) (582) 762
Net cash and cash equivalents provided by (used in) operating activities 1,421 11,948 5,159
Cash flows from investing activities:      
Acquisitions, net of cash acquired (3,050) (7,230) (80,784)
Purchase of property and equipment (6,698) (12,896) (18,740)
Purchase of marketable securities (98,680) (38,692) (75,000)
Maturities of marketable securities 96,758 46,633 35,207
Proceeds from disposals of assets 265 612 0
Net cash and cash equivalents provided by (used in) investing activities (11,405) (11,573) (139,317)
Cash flows from financing activities:      
Principal payments on long term debt (50) (108) (83)
Common stock withheld for employee payroll taxes (263) (1,618) (4,391)
Proceeds from the sales of common stock and exercise of warrants and options, net of expenses 0 33 2,092
Net cash and cash equivalents (used in) provided by financing activities (313) (1,693) (2,382)
Net increase (decrease) in cash and cash equivalents (10,297) (1,318) (136,540)
Cash and cash equivalents at beginning of year 40,054 41,372 177,912
Cash and cash equivalents at end of year 29,757 40,054 41,372
Supplemental Information:      
Cash paid for interest 98 21 43
Cash paid for income taxes 93 0 6,072
Right to use assets acquired under new operating leases 4,289 9,607 32,875
Indemnity holdback from business acquisition 0 875 0
Non-cash repurchase of liability awards 653 0 0
Non-cash issuance of a note receivable 299 0 0
Common stock issued for business combinations 0 5,710 37,272
Liability redemption associated with business acquisition 120 0 0
Common stock issued for intangible assets $ 0 $ 173 $ 168

Source

HTML PDF
ZIP